Invasive mould infection in children – advances made or obstacles remaining?
Invasive mould infection (IMI) is a major cause of morbidity and mortality in immunocompromised children. Outcomes for paediatric patients with IMI remain poor, due in part to the limitations of available diagnostic tools and therapeutic agents.
Keywords:
Antifungals; Aspergillosis; Children; Diagnostic imaging; Fusariosis; Invasive fungal disease; Mucormycosis; Scedosporiosis
Abstract:
Invasive mould infection (IMI) is a major cause of morbidity and mortality in immunocompromised children. Outcomes for paediatric patients with IMI remain poor, due in part to the limitations of available diagnostic tools and therapeutic agents.